EUVIMEDEUVIMED entdecken
Crossref

Icariin attenuates asthmatic airway inflammation via modulating alveolar macrophage activation based on network pharmacology and in vivo experiments

Xiaofei Zhu, Bin Wang, Hang Yu, Congcong Li, Yuhang Zhao, Yuanyuan Zhong, Weifeng Tang, Yaolong Zhou, Xi Huang, Huahe Zhu, Yueren Wu, Kai Yang und 3 weitere

The Journal of Gene Medicine · 2024

DOI: 10.1002/jgm.3718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Xiaofei Zhu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Asthma, Flavonoids, Macrophages, Alveolar, Macrophage Activation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Shanghai Municiple Commission of Science and Technology, National Natural Science Foundation of China, Organiztion Department of Yunnan Provincial Party Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Icariin (ICA) inhibits inflammatory response in various diseases, but the mechanism underlying ICA treating airway inflammation in asthma needs further understood. We aimed to predict and validate the potential targets of ICA against asthma‐associated airway inflammation using network pharmacology and experiments.

Methods

The ovalbumin‐induced asthma‐associated airway inflammation mice model was established. The effects of ICA were evaluated by behavioral, airway hyperresponsiveness, lung pathological changes, inflammatory cell and cytokines counts. Next, the corresponding targets of ICA were mined via the SEA, CTD, HERB, PharmMapper, Symmap database and the literature. Pubmed‐Gene and GeneCards databases were used to screen asthma and airway inflammation‐related targets. The overlapping targets were used to build an interaction network, analyze gene ontology and enrich pathways. Subsequently, flow cytometry, quantitative real‐time PCR and western blotting were employed for validation.

Results

ICA alleviated the airway inflammation of asthma; 402 targets of ICA, 5136 targets of asthma and 4531 targets of airway inflammation were screened; 216 overlapping targets were matched and predicted ICA possesses the potential to modulate asthmatic airway inflammation by macrophage activation/polarization. Additionally, ICA decreased M1 but elevated M2. Potential targets that were disrupted by asthma inflammation were restored by ICA treatment.

Conclusions

ICA alleviates airway inflammation in asthma by inhibiting the M1 polarization of alveolar macrophages, which is related to metabolic reprogramming. Jun , Jak2 , Syk , Tnf , Aldh2 , Aldh9a1 , Nos1 , Nos2 and Nos3 represent potential targets of therapeutic intervention. The present study enhances understanding of the anti‐airway inflammation effects of ICA, especially in asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaFlavonoidsMacrophages, AlveolarMacrophage ActivationDisease Models, AnimalNetwork PharmacologyAnimalsMiceInflammationCytokinesOvalbuminLungFemale

Stichwörter der Autor:innen

airway inflammationasthmaicariinmacrophage activationnetwork pharmacology

Substanzen

icariinFlavonoidsCytokinesOvalbumin

Autor:innen und Institutionen

  • Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • Institute of Integrative Medicine, Fudan University, Shanghai, China.

ORCID-Profile: Jingcheng Dong

Förderung

  • Shanghai Municiple Commission of Science and Technology
  • National Natural Science Foundation of China
  • Organiztion Department of Yunnan Provincial Party Committee
  • Project of Huashan Hospital affiliated to Fudan University

Zitieren

APA

Zhu, X., Wang, B., Yu, H., Li, C., Zhao, Y., Zhong, Y., Tang, W., Zhou, Y., Huang, X., Zhu, H., Wu, Y., Yang, K., Wei, Y., Gao, Z., & Dong, J. (2024). Icariin attenuates asthmatic airway inflammation via modulating alveolar macrophage activation based on network pharmacology and in vivo experiments. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3718

Vancouver

Zhu X, Wang B, Yu H, Li C, Zhao Y, Zhong Y, et al. Icariin attenuates asthmatic airway inflammation via modulating alveolar macrophage activation based on network pharmacology and in vivo experiments. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3718

BibTeX
@article{Zhu2024,
  author = {Zhu, Xiaofei and Wang, Bin and Yu, Hang and Li, Congcong and Zhao, Yuhang and Zhong, Yuanyuan and Tang, Weifeng and Zhou, Yaolong and Huang, Xi and Zhu, Huahe and Wu, Yueren and Yang, Kai and Wei, Ying and Gao, Zhen and Dong, Jingcheng},
  title = {Icariin attenuates asthmatic airway inflammation via modulating alveolar macrophage activation based on network pharmacology and in vivo experiments},
  journal = {The Journal of Gene Medicine},
  year = {2024},
  doi = {10.1002/jgm.3718}
}
Kostenlos starten →